Edarbi 40mg, Tabletten - 14 Swissmedic Key 62158017 PP Registration Holder Takeda Pharma AG Name Edarbi 40mg, Tabletten Date of registration 31.08.2012 Introduction of Sequence 31.08.2012 ATC-Classification Azilsartan Medoxomil (C09CA09) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.07.10. Show package size 14 Index Therapeuticus (Swissmedic) 02.07.10. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680621580179 Medication Code Synthetika Pharmacode Disponibility
Composition azilsartanum medoxomilum 40 mg ut azilsartanum medoxomilum kalicum 42.68 mg, mannitolum, acidum fumaricum, natrii hydroxidum, hydroxypropylcellulosum, carmellosum natricum conexum, cellulosum microcristallinum, magnesii stearas, pro compresso, natrium 1.60 mg. Packungsbestandteile Galenic Form Tablets Active Agent Dose Azilsartanum Medoxomilum 40 mg
BAG: Active Agent Dose Azilsartanum Medoxomilum 40 mg
Inactive agents Dose Acidum Fumaricum Carmellosum Natricum Conexum Cellulosum Microcristallinum Hydroxypropylcellulosum Magnesii Stearas Mannitol Sodium Hydroxide Sodium 1.6 mg Pro Compresso
Source Data was imported : 04.11.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
